Investment

Polari Group Secures $539K Pre-Seed Funding to Advance Anal Health and Pleasure

Polari Group has secured $539K in pre-seed funding to advance their work in anal health and pleasure. The funding round was supported by Ventures Together, Ada Ventures (Ada Angel Program), Chasing Rainbows, Little Green Bamboo Capital, and a series of international angel investors. Founded in 2023 by bioengineer Anna Vybornova and chemist and immunologist Dr. Henry Blest, Polari Group aims to improve…

Grayce Secures $10.4M in Series A Funding to Expand Its Suite of Family Care Solutions

Grayce has announced the successful closure of a $10.4 million Series A funding round led by Maveron and supported by an array of investors including BBG Ventures and Correlation Ventures among others. With the fresh funds Grayce aims to expand its digital platform designed to assist families in managing care for their loved ones. Founded in San Francisco, Grayce has developed a…

OCON Therapeutics Raises $10M to Advance Treatments for Abnormal and Heavy Uterine Bleeding

OCON Therapeutics has announced the successful completion of a $10 million investment round led by RH Capital. This funding will enhance OCON’s efforts to develop treatments for prevalent uterine pathologies using its proprietary 3D drug delivery system. The company focuses on developing drug delivery systems to address significant issues in women’s health. The company’s 3D stent drug delivery frame, IUB, has been…

Pomelo Care Secures $46M Series B Funding to Expand Virtual Maternal and Infant Care

Pomelo Care, a virtual medical practice focused on improving maternal and newborn health, has announced a successful $46 million Series B funding round. The funding, led by First Round Capital and Andreessen Horowitz (a16z) Bio + Health, aims to scale Pomelo’s care model in the U.S. Pomelo Care’s mission is driven by concerning statistics in maternal and infant health in the U.S.…

Amber Therapeutics Secures $100M Series A Funding for Neuromodulation Therapy for Mixed Urinary Incontinence

Amber Therapeutics, a UK-based medical technology company, has successfully closed a $100 million Series A financing round. The investment will advance their Amber-UI neuromodulation therapy towards US FDA approval. The financing round, one of the largest ever in Europe for a medical technology company, was led by New Enterprise Associates (NEA) with participation from F-Prime Capital, Lightstone Ventures, Intuitive Ventures, and existing…

AI-Based Sexual Wellness Platform Arya Raises $7.5M Seed Round

Arya, an AI-driven sexual wellness platform for couples, has secured $7.5 million in a seed funding round co-led by Patron and Play Ventures. This financial boost comes alongside the announcement that renowned sexologist and relationship expert, Shan Boodram, has joined Arya as the Chief Intimacy Officer. The fresh funds will propel Arya’s mission to enhance intimacy and sexual wellness among couples through…

Femtech Venture Studio Daya Secures Strategic Investment Round Led by International VC Fund Nextblue

Women’s Health focused venture builder Daya Ventures AB (Daya) has recently announced the closing of its pre-seed investment round, led by Nextblue, an international VC fund known for supporting startups in Europe and Japan. Additional investors in this round include Vera Invest, Peter Strömberg (ex-Avanza), and key members of the Daya team. The terms of the deal were not disclosed. Daya emerged…

Maternal and Fetal Health Company Raydiant Oximetry Secures $7.5M in Oversubscribed Series A Extension Round

Raydiant Oximetry, a clinical-stage medical device company focused on improving outcomes for mothers and babies during childbirth has closed an oversubscribed $7.5 million Series A3 extension round. The round was led by Cross-Border Impact Ventures (CBIV), a VC fund focused on the health of women and children worldwide. The round also included participation from RH Capital, Global Health Impact Fund, VCapital, and…